Skip to main content
. 2019 Feb 28;26(5):552–561. doi: 10.1007/s12282-019-00955-6

Fig. 2.

Fig. 2

Transverse first dynamic contrast-enhanced MR image in an asymptomatic 52-year-old female BRCA1 mutation carrier for post-operative follow-up evaluation, which revealed a 5 mm mass lesion (arrow) in the left breast. Through MRI-guided biopsy, this case was diagnosed as invasive ductal cancer, triple-negative